Literature DB >> 1019668

Long-term follow-up of hip fractures.

P L McCown, W A Miller.   

Abstract

Hip fractures on 117 patients treated surgically and followed up for an average of 10.2 months are reviewed. Among the parameters analyzed were complications, mortality, clinical follow-up by the operating surgeon, and the ability to ambulate after surgery. Postoperative surgical complications occurred in 36% and medical complications in 18% of the patients. Mortality was 25% within the first year after surgery. Sixty-one percent of the patients returned at least once to the surgeon's office for follow-up; only 38% were followed for more than six months. In the surviving patients who were good ambulators before hip fracture, 60% to 70% became good ambulators postoperatively. Only 20% to 30% of the surviving patients who were poor ambulators preoperatively ever walked again.

Entities:  

Mesh:

Year:  1976        PMID: 1019668     DOI: 10.1097/00007611-197612000-00007

Source DB:  PubMed          Journal:  South Med J        ISSN: 0038-4348            Impact factor:   0.954


  4 in total

Review 1.  Prognosis and rehabilitation after hip fracture.

Authors:  K Obrant
Journal:  Osteoporos Int       Date:  1996       Impact factor: 4.507

2.  Survival experience of aged hip fracture patients.

Authors:  J Magaziner; E M Simonsick; T M Kashner; J R Hebel; J E Kenzora
Journal:  Am J Public Health       Date:  1989-03       Impact factor: 9.308

3.  Excess mortality attributable to hip fracture in white women aged 70 years and older.

Authors:  J Magaziner; E Lydick; W Hawkes; K M Fox; S I Zimmerman; R S Epstein; J R Hebel
Journal:  Am J Public Health       Date:  1997-10       Impact factor: 9.308

4.  Predictors of mortality and institutionalization after hip fracture: the New Haven EPESE cohort. Established Populations for Epidemiologic Studies of the Elderly.

Authors:  R A Marottoli; L F Berkman; L Leo-Summers; L M Cooney
Journal:  Am J Public Health       Date:  1994-11       Impact factor: 9.308

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.